Trial
NCT00233948
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
City of Hope Medical Center
Collaborators
—
Condition
Adult Liposarcoma
Intervention
nelfinavir mesylate
Why stopped
Drug availability issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-01